PROJECT #16516 RESEARCH FOR COVID-19
FOLDING PERFORMANCE PROFILE
PROJECT SUMMARY
This series of CPU projects to simulation the Nonstructural protein 12 (nsp12) and Nonstructural protein 14 (nsp14) complexes.
We will screen existing FDA-approved NTP analog drugs (e.g.
Ribirine).
We aim to repurpose drugs that can inhibit SARS-CoV-2 replication 16500: This project contains simulations of nsp14-ExoN and nsp10 of the SARS-CoV-2 in complex with a short nascent RNA.
Nsp14 is in charge of proofeading of the replication SARS-CoV-2 by removing mis-incoproated nucleotides including drugs, so that it is important that NTP analog drugs (e.g.
Remdesivir) added to the nascent RNA do not get cleaved by nsp14. 16501: This project contains simulations of nsp12, nsp7, and nsp8 of the SARS-CoV-2 in complex with the RNA template, a short nascent RNA, and Ribavirin Triphosphate in the active site.
We aim to examine if the drug Ribirine can inhibite the viral replicaiton of SARS-CoV-2. 16502: This project contains simulations of nsp12, nsp7 and nsp8 of the SARS-CoV-2 in complex with the RNA template, a short nascent RNA with Ribavirin as the 3’ terminal nucleotide. 16503: Nonstructural protein 12 (nsp12-RdRp & nsp7 & nsp8) of the SARS-CoV-2 in complex with the RNA template, a short nascent RNA and Cladribine Triphosphate in the active site. 16504: Nonstructural protein 12 (nsp12-RdRp & nsp7 & nsp8) of the SARS-CoV-2 in complex with the RNA template, a short nascent RNA and Clofarabine Triphosphate in the active site. 16505: Nonstructural protein 12 (nsp12-RdRp & nsp7 & nsp8) of the SARS-CoV-2 in complex with the RNA template, a short nascent RNA and Cordycepin Triphosphate in the active site.
16506: Nonstructural protein 12 (nsp12-RdRp & nsp7 & nsp8) of the SARS-CoV-2 in complex with the RNA template, a short nascent RNA(Cladribine at 3'-terminal), and ATP in the active site.
16507: Nonstructural protein 12 (nsp12-RdRp & nsp7 & nsp8) of the SARS-CoV-2 in complex with the RNA template, a short nascent RNA(Clofarabine at 3'-terminal), and ATP in the active site. 16508: Nonstructural protein 12 (nsp12-RdRp & nsp7 & nsp8) of the SARS-CoV-2 in complex with the RNA template, a short nascent RNA(Cordycepin at 3'-terminal), and ATP in the active site. 16509: Nonstructural protein 14 and 10 (nsp14-ExoN & nsp 10) of the SARS-CoV-2 in complex with a short nascent RNA containing Cordycepin at 3'-terminal. 16510: Nonstructural protein 14 and 10 (nsp14-ExoN & nsp 10) of the SARS-CoV-2 in complex with a short nascent RNA containing Clofarabine at 3'-terminal. 16513: Nonstructural protein 12 (nsp12-RdRp & nsp7 & nsp8) of the SARS-CoV-2 in complex with the RNA template, a short nascent RNA, and ATP in the active site. 16514: Nonstructural protein 12 (nsp12-RdRp & nsp7 & nsp8) of the SARS-CoV-2 in complex with the RNA template, a short nascent RNA, and GTP in the active site. 16515: Nonstructural protein 12 (nsp12-RdRp & nsp7 & nsp8) of the SARS-CoV-2 in complex with the RNA template, a short nascent RNA, and GTP in the active site with nonbonded dummy ion model. 16516: Nonstructural protein 12 (nsp12-RdRp & nsp7 & nsp8) of the SARS-CoV-2 in complex with the RNA template, a short nascent RNA, and ATP in the active site with nonbonded dummy ion model..
PROJECT INFO
Manager(s): Prof. Xuhui Huang
Institution: Hong Kong University of Science and Technology
PROJECT WORK UNIT SUMMARY
Atoms: 226,497
Core: GRO_A7
Status: Public
PROJECT FOLDING PPD AVERAGES BY GPU
PPDDB data as of Tuesday, 31 January 2023 00:15:03
Rank Project |
Model Name Folding@Home Identifier |
Make Brand |
GPU Model |
PPD Average |
Points WU Average |
WUs Day Average |
WU Time Average |
---|
PROJECT FOLDING PPD AVERAGES BY CPU BETA
PPDDB data as of Tuesday, 31 January 2023 00:15:03
Rank Project |
CPU Model |
Logical Processors (LP) |
PPD-PLP AVG PPD per 1 LP |
ALL LP-PPD (Estimated) |
Make |
---|---|---|---|---|---|
1 | RYZEN THREADRIPPER 3970X 32-CORE | 64 | 17,459 | 1,117,376 | AMD |
2 | RYZEN THREADRIPPER 3960X 24-CORE | 48 | 13,790 | 661,920 | AMD |
3 | RYZEN 9 3950X 16-CORE | 32 | 18,860 | 603,520 | AMD |
4 | CORE I9-10900X CPU @ 3.70GHZ | 20 | 10,360 | 207,200 | Intel |
5 | CORE I9-7920X CPU @ 2.90GHZ | 24 | 7,109 | 170,616 | Intel |
6 | CORE I9-7940X CPU @ 3.10GHZ | 28 | 5,370 | 150,360 | Intel |
7 | RYZEN 7 3700X 8-CORE | 16 | 7,800 | 124,800 | AMD |
8 | RYZEN 5 3600X 6-CORE | 12 | 9,687 | 116,244 | AMD |
9 | RYZEN 7 3800X 8-CORE | 16 | 6,067 | 97,072 | AMD |
10 | XEON CPU E5-2660 0 @ 2.20GHZ | 32 | 2,983 | 95,456 | Intel |
11 | RYZEN 7 2700X EIGHT-CORE | 16 | 4,606 | 73,696 | AMD |
12 | XEON CPU E5-2690 V2 @ 3.00GHZ | 20 | 3,478 | 69,560 | Intel |
13 | CORE I7-8700K CPU @ 3.70GHZ | 12 | 5,358 | 64,296 | Intel |
14 | RYZEN 5 2600 SIX-CORE | 12 | 4,862 | 58,344 | AMD |
15 | RYZEN 5 3600 6-CORE | 12 | 4,651 | 55,812 | AMD |
16 | CORE I5-8400 CPU @ 2.80GHZ | 6 | 8,670 | 52,020 | Intel |
17 | CORE I3-6006U CPU @ 2.00GHZ | 4 | 1,908 | 7,632 | Intel |